Media headlines about DENTSPLY SIRONA (NASDAQ:XRAY) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. DENTSPLY SIRONA earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave news articles about the medical instruments supplier an impact score of 46.2336227399088 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the news headlines that may have impacted Accern’s scoring:
- $1.06 Billion in Sales Expected for DENTSPLY SIRONA Inc (XRAY) This Quarter (americanbankingnews.com)
- DENTSPLY SIRONA Inc (XRAY) Expected to Announce Earnings of $0.81 Per Share (americanbankingnews.com)
- Eric Brandt Sells 6,409 Shares of DENTSPLY SIRONA Inc (XRAY) Stock (americanbankingnews.com)
- DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Track P/E Before Buying A Stock – Nasdaq Journal (press release) (nasdaqjournal.com)
- Tale of the Ticker: Dentsply Sirona Inc (XRAY), Future Fintech Group Inc (FTFT) Moving on Volume – Clawson News (clawsonnews.com)
XRAY has been the subject of several recent analyst reports. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, October 30th. Cleveland Research cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Thursday, October 5th. BidaskClub cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 2nd. HC Wainwright restated a “buy” rating and issued a $68.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, October 3rd. Finally, Robert W. Baird set a $63.00 target price on shares of DENTSPLY SIRONA and gave the stock a “buy” rating in a research note on Thursday, October 19th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $69.15.
Shares of DENTSPLY SIRONA (XRAY) traded down $0.14 during midday trading on Tuesday, hitting $65.65. 1,236,194 shares of the company traded hands, compared to its average volume of 2,323,260. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59. DENTSPLY SIRONA has a 12-month low of $52.53 and a 12-month high of $68.98. The firm has a market capitalization of $15,110.00, a PE ratio of -18.86, a price-to-earnings-growth ratio of 2.42 and a beta of 1.31.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The firm had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $978.99 million. During the same quarter last year, the business earned $0.66 earnings per share. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. research analysts forecast that DENTSPLY SIRONA will post 2.65 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 12th. Investors of record on Friday, December 29th were paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Thursday, December 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.06%.
In related news, Director Eric Brandt sold 6,409 shares of the firm’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the completion of the sale, the director now owns 12,073 shares in the company, valued at $821,446.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Mark Thierer bought 77,000 shares of the company’s stock in a transaction on Monday, November 13th. The shares were acquired at an average price of $66.04 per share, with a total value of $5,085,080.00. The disclosure for this purchase can be found here. 1.99% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: This report was reported by TrueBlueTribune and is the property of of TrueBlueTribune. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.truebluetribune.com/2018/01/16/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-dentsply-sirona-xray-share-price.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.